Infectoazit

Azithromycin, the active ingredient in Infectoazit, is a macrolide antibiotic presented as an ocular preparation for ophthalmic use. It treats bacterial infections of the eye such as conjunctivitis and blepharitis in patients requiring prescription therapy.

GNH USA supplies Infectoazit as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Infectoazit, a macrolide antibiotic, is used to manage bacterial eye conditions.

- Bacterial conjunctivitis: reduces bacterial load and accelerates resolution of redness and discharge. - Blepharitis: controls bacterial overgrowth on the eyelid margin, improving inflammation. - Other ocular bacterial infections: targets susceptible Gram‑positive and Gram‑negative organisms to restore ocular health.

Adverse reactions may occur with ocular azithromycin use.

Common Side Effects: - Eye irritation or burning sensation. - Redness of the conjunctiva. - Blurred vision. - Foreign body sensation. - Mild itching. - Temporary tearing.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with swelling of the eyelids. - Stevens‑Johnson syndrome or toxic epidermal necrolysis involving the eye. - Significant vision loss or corneal ulceration. - Persistent severe eye pain. - Development of resistant bacterial infection.

Use Infectoazit with caution and follow prescribing guidance.

- Allergy assessment: avoid if known hypersensitivity to macrolides. - Confirm bacterial etiology before initiating therapy. - Do not wear contact lenses during treatment unless advised. - Monitor for worsening infection or signs of allergic reaction. - Use only as prescribed; do not exceed recommended duration. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Azithromycin ocular solution may interact with systemic and topical agents.

Major Interactions (Avoid): - Concurrent use of other macrolide antibiotics: risk of additive toxicity. - Drugs that prolong QT interval (e.g., certain antiarrhythmics): may increase cardiac risk. - Antacids containing aluminum or magnesium: can reduce systemic absorption if taken orally.

Moderate Interactions (Monitor Closely): - Warfarin: monitor INR for potential anticoagulant effect enhancement. - Corticosteroid eye drops: increased risk of ocular side effects. - Other ophthalmic antibiotics: assess for antagonistic activity.